The Mechanism of Anti-Inflammatory Effects of Prostaglandin E2 Receptor 4 Activation in Murine Cardiac Transplantation

Background. Prostaglandin E2 (PGE2) is a pathogenesis of inflammatory diseases; PGE2 plays a key role in association of anti-inflammation and immune suppression. EP4, which is a PGE2 receptor, is known to suppress the production of inflammatory cytokines and chemokines in vitro. Although it has been reported that EP4 agonists prolonged cardiac allograft survival, little has been elucidated the immunologic mechanism. Methods. We injected a selective EP4 agonist (EP4RAG) into recipient mice with heterotopic cardiac transplantation. Results. EP4RAG significantly prolonged the graft survival compared with the vehicle-treated group. Although the vehicle-treated group showed severe myocardial cell infiltration, the EP4RAG-treated group attenuated the development on day 7. EP4RAG suppressed various proinflammatory factors such as cytokines, chemokines, adhesion molecules, and nuclear factor-&kgr;B (NF-&kgr;B) compared with the vehicle-treated group. We also demonstrated that EP4RAG suppressed the activation of macrophages, but it did not affect to T lymphocytes in vitro. EP4RAG inhibited the activation of NF-&kgr;B compared with the control group. Conclusion. Pharmacological selective EP4 activation suppressed the production of proinflammatory factors by inhibition of NF-&kgr;B activity in cardiac transplantation.

[1]  M. Isobe,et al.  A specific COX-2 inhibitor attenuates cell infiltration but does not prolong graft survival in murine cardiac transplantation. , 2005, Transplantation proceedings.

[2]  M. Isobe,et al.  Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia/reperfusion injury. , 2009, Cardiovascular research.

[3]  T. Okamoto,et al.  Inhibition of the NF-κB transcriptional activity by protein kinase A , 2002 .

[4]  T. Okamoto,et al.  Inhibition of the NF-kappaB transcriptional activity by protein kinase A. , 2002, European journal of biochemistry.

[5]  C. Hsieh,et al.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.

[6]  R. Simmons,et al.  PARTIAL CHARACTERIZATION OF CYTOTOXIC CELLS INFILTRATING SPONGE MATRIX ALLOGRAFTS , 1979, Transplantation.

[7]  J. Mcgiff,et al.  Arachidonic acid metabolism. , 1987, Preventive medicine.

[8]  B. Koller,et al.  Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. , 2001, The Journal of clinical investigation.

[9]  Wan-Wan Lin,et al.  Pyrimidinoceptor potentiation of macrophage PGE2 release involved in the induction of nitric oxide synthase , 2000, British journal of pharmacology.

[10]  C. Turck,et al.  Prostaglandin E2 enhancement of interferon-gamma production by antigen-stimulated type 1 helper T cells. , 1999, Cellular immunology.

[11]  M. Kazanietz,et al.  Decreased β-adrenoceptor-mediated vasodilation in aorta from aged rats: possible involvement of a stimulatory GTP-binding protean , 1991 .

[12]  P. Libby,et al.  Prostaglandin E Receptor Type 4-associated Protein Interacts Directly with NF-κB1 and Attenuates Macrophage Activation* , 2008, Journal of Biological Chemistry.

[13]  E. Hooghe-Peters,et al.  Mechanism of Prostaglandin (PG)E2-Induced Prolactin Expression in Human T Cells: Cooperation of Two PGE2 Receptor Subtypes, E-Prostanoid (EP) 3 and EP4, Via Calcium- and Cyclic Adenosine 5′-Monophosphate-Mediated Signaling Pathways1 , 2004, The Journal of Immunology.

[14]  S. Narumi,et al.  Differential induction of interferon (IFN)-inducible protein 10 following differentiation of a monocyte, macrophage cell lineage is related to the changes of nuclear proteins bound to IFN stimulus response element and kappaB sites. , 1999, International journal of molecular medicine.

[15]  M. Betz,et al.  Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. , 1991, Journal of immunology.

[16]  P. Libby,et al.  A Novel Prostaglandin E Receptor 4–Associated Protein Participates in Antiinflammatory Signaling , 2006, Circulation research.

[17]  S. Fazel,et al.  Microsomal Prostaglandin E2 Synthase-1 Deletion Leads to Adverse Left Ventricular Remodeling After Myocardial Infarction , 2008, Circulation.

[18]  M. Isobe,et al.  New approaches to the management of acute and chronic cardiac allograft rejection. , 1998, Japanese circulation journal.

[19]  E. Puré,et al.  Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis , 2006, Proceedings of the National Academy of Sciences.

[20]  G. Peluso,et al.  Role of monocyte/macrophage population in immune response. , 1998, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[21]  P. Libby,et al.  Prostaglandin E2 Suppresses Chemokine Production in Human Macrophages through the EP4 Receptor* , 2002, The Journal of Biological Chemistry.

[22]  M. Isobe,et al.  Clarithromycin attenuates acute and chronic rejection via matrix metalloproteinase suppression in murine cardiac transplantation. , 2008, Journal of the American College of Cardiology.

[23]  G. Trinchieri,et al.  Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones , 1994, The Journal of experimental medicine.

[24]  G. Ghosh,et al.  IκBα Functions through Direct Contacts with the Nuclear Localization Signals and the DNA Binding Sequences of NF-κB* , 1998, The Journal of Biological Chemistry.

[25]  Patricia Renard,et al.  Development of a sensitive multi-well colorimetric assay for active NFκB , 2001 .

[26]  S. Ohno,et al.  NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. , 1994, Journal of immunology.

[27]  K. Metters,et al.  Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype. , 1994, The Journal of biological chemistry.

[28]  J. Blackwell,et al.  Induction of early-response genes KC and JE by mycobacterial lipoarabinomannans: regulation of KC expression in murine macrophages by Lsh/Ity/Bcg (candidate Nramp) , 1994, Infection and immunity.

[29]  B. Koller,et al.  Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. , 2001, The Journal of clinical investigation.

[30]  A. Cerami,et al.  Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP)-2, MIP-1 alpha, and MIP-1 beta, members of the chemokine superfamily of proinflammatory cytokines. , 1993, Journal of immunology.

[31]  M. Isobe,et al.  Tea catechins attenuate ventricular remodeling and graft arterial diseases in murine cardiac allografts. , 2006, Cardiovascular research.

[32]  A. Itai,et al.  A novel IKK inhibitor suppresses heart failure and chronic remodeling after myocardial ischemia via MMP alteration. , 2008, Expert opinion on therapeutic targets.

[33]  S. Narumiya,et al.  International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. , 1994, Pharmacological reviews.

[34]  J. Remacle,et al.  Development of a sensitive multi-well colorimetric assay for active NFkappaB. , 2001, Nucleic acids research.

[35]  M. Isobe,et al.  Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. , 1992, Science.

[36]  Marshall I Hertz,et al.  Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report--2005. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[37]  M. Southall,et al.  Prostaglandin Receptor Subtypes, EP3C and EP4, Mediate the Prostaglandin E2-induced cAMP Production and Sensitization of Sensory Neurons* , 2001, The Journal of Biological Chemistry.

[38]  M. Isobe,et al.  Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway1 , 2003, Transplantation.

[39]  G. Ghosh,et al.  Ikappa Balpha functions through direct contacts with the nuclear localization signals and the DNA binding sequences of NF-kappaB. , 1998, The Journal of biological chemistry.

[40]  J. Fabre,et al.  Massive induction of donor-type class I and class II major histocompatibility complex antigens in rejecting cardiac allografts in the rat , 1985, The Journal of experimental medicine.

[41]  A. Sher,et al.  Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Y. Nakajima,et al.  Protective effect of prostaglandin E2 receptors EP2 and EP4 in alloimmune response in vivo. , 2006, Transplantation proceedings.

[43]  M. Kazanietz,et al.  Decreased beta-adrenoceptor-mediated vasodilation in aorta from aged rats: possible involvement of a stimulatory GTP-binding protein. , 1991, European journal of pharmacology.

[44]  T. Yoshino,et al.  Effect of prostaglandin E2 on intercellular adhesion molecule-1 and B7 expression in mixed lymphocyte reaction1 , 2003, Transplantation.

[45]  M. Gunzer,et al.  Two-step negative enrichment of CD4+ and CD8+ T cells from murine spleen via nylon wool adherence and an optimized antibody cocktail. , 2001, Journal of immunological methods.

[46]  U. Yamashita,et al.  Mechanisms of Enhanced Macrophage-Mediated Prostaglandin E2 Production and Its Suppressive Role in Th1 Activation in Th2-Dominant BALB/c Mice1 , 2003, The Journal of Immunology.

[47]  B. Levine,et al.  Cyclooxygenase-2 inhibition with celecoxib enhances antitumor efficacy and reduces diarrhea side effect of CPT-11. , 2002, Cancer research.